131 related articles for article (PubMed ID: 21556735)
1. Farnesyltransferase inhibitor manumycin targets IL1β-Ras-HIF-1α axis in tumor cells of diverse origin.
Sharma V; Shaheen SS; Dixit D; Sen E
Inflammation; 2012 Apr; 35(2):516-9. PubMed ID: 21556735
[TBL] [Abstract][Full Text] [Related]
2. Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.
Sharma V; Dixit D; Koul N; Mehta VS; Sen E
J Mol Med (Berl); 2011 Feb; 89(2):123-36. PubMed ID: 20865400
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.
Saha B; Nandi D
Hepatology; 2009 Nov; 50(5):1547-57. PubMed ID: 19739265
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma.
Sinha S; Koul N; Dixit D; Sharma V; Sen E
Cell Signal; 2011 Nov; 23(11):1869-75. PubMed ID: 21756999
[TBL] [Abstract][Full Text] [Related]
5. Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells.
Zhou JM; Zhu XF; Pan QC; Liao DF; Li ZM; Liu ZC
Int J Mol Med; 2003 Jun; 11(6):767-71. PubMed ID: 12736720
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between inhibitory effect of Manumycin on human hepatoma cancer cell HepG2 and Ras signal transduction pathway].
Zhou JM; Pan QC; Yang XP; Liu ZC; Liao DF; Fu LW; Liang YJ
Ai Zheng; 2002 Apr; 21(4):364-8. PubMed ID: 12452012
[TBL] [Abstract][Full Text] [Related]
7. Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation.
Dixit D; Sharma V; Ghosh S; Koul N; Mishra PK; Sen E
Free Radic Biol Med; 2009 Aug; 47(4):364-74. PubMed ID: 19409983
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane-induced rat colorectal carcinogenesis model.
Tsuda M; Okamoto K; Muguruma N; Sannomiya K; Nakagawa T; Miyamoto H; Kitamura S; Goji T; Kimura T; Okahisa T; Izumi K; Takayama T
J Gastroenterol Hepatol; 2013 Oct; 28(10):1616-23. PubMed ID: 23730936
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A.
Sačková V; Kuliková L; Kello M; Uhrinová I; Fedoročko P
Int J Mol Sci; 2011; 12(12):8388-405. PubMed ID: 22272079
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
Sugita M; Sugita H; Kaneki M
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α.
Naldini A; Filippi I; Miglietta D; Moschetta M; Giavazzi R; Carraro F
Eur J Cancer; 2010 Dec; 46(18):3400-8. PubMed ID: 20801015
[TBL] [Abstract][Full Text] [Related]
12. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the Ras pathway by manumycin, a farnesyltransferase inhibitor, overcomes the resistance of myeloma plasma cells to Fas-induced apoptosis.
Frassanito MA; Mastromauro L; Cusmai A; Dammacco F
Clin Exp Med; 2005 Mar; 4(4):174-82. PubMed ID: 15750764
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin.
Kainuma O; Asano T; Hasegawa M; Kenmochi T; Nakagohri T; Tokoro Y; Isono K
Pancreas; 1997 Nov; 15(4):379-83. PubMed ID: 9361092
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635
[TBL] [Abstract][Full Text] [Related]
16. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.
Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH
Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248
[TBL] [Abstract][Full Text] [Related]
17. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis.
Jung YJ; Isaacs JS; Lee S; Trepel J; Neckers L
FASEB J; 2003 Nov; 17(14):2115-7. PubMed ID: 12958148
[TBL] [Abstract][Full Text] [Related]
18. Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor.
Park D; Pandey SK; Maksimova E; Kole S; Bernier M
Biochemistry; 2000 Oct; 39(41):12513-21. PubMed ID: 11027130
[TBL] [Abstract][Full Text] [Related]
19. Salternamide A Suppresses Hypoxia-Induced Accumulation of HIF-1α and Induces Apoptosis in Human Colorectal Cancer Cells.
Bach DH; Kim SH; Hong JY; Park HJ; Oh DC; Lee SK
Mar Drugs; 2015 Nov; 13(11):6962-76. PubMed ID: 26610526
[TBL] [Abstract][Full Text] [Related]
20. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
